Literature DB >> 2175294

Chondroid syringoma: a histological and immunohistochemical study of 15 cases.

F Dominguez Iglesias1, F Fresno Forcelledo, T Soler Sanchez, L Fernandez García, A Herrero Zapatero.   

Abstract

Fifteen cases of chondroid syringoma have been studied histologically and by immunohistochemical methods in an attempt to establish their phenotypic profile and to elucidate their histogenesis. The epithelial elements were classified as tubuloglandular, solid nests and stromal cells. The inner cell layers of tubuloglandular components had distinct epithelial features, expressing cytokeratin, carcino-embryonic antigen and epithelial membrane antigen. The outer cell layers expressed vimentin, S-100 protein, neuron-specific enolase and muscle-specific actin and were negative for epithelial markers. The immunophenotypes of stromal cells and solid nests were similar to those of the outer cell layers. These data suggest that the stromal components may derive from the outer cell of tubuloglandular elements and that myo-epithelial cells have an important role in the histogenesis of these lesions and in their mesenchymal matrix production.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175294     DOI: 10.1111/j.1365-2559.1990.tb00734.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Malignant chondroid syringoma presenting as multiple pulmonary nodules.

Authors:  J L Kiely; B Dunne; M McCabe; W T McNicholas
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

2.  Benign myoepithelioma of the lung - a case report and review of the literature.

Authors:  Jihene Kourda; Olfa Ismail; Bel Hssan Smati; Aida Ayadi; Tarek Kilani; Faouzi El Mezni
Journal:  Cases J       Date:  2010-01-13

3.  [Mixed tumor of the skin].

Authors:  M Zirbs; A Konstantinow; M Ziai; K Brockow; R Hein; J Ring
Journal:  Hautarzt       Date:  2011-09       Impact factor: 0.751

4.  Chondroid syringoma of the eyelid.

Authors:  M Martorina; C Capoferri; P Dessanti
Journal:  Int Ophthalmol       Date:  1993-10       Impact factor: 2.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.